Next, we analyzed LSD1 and SESN2 expression in a microarray gene expression data of 61 NBs (GSE12460), of which 50 were NB, 9 were ganglioblastoma and ganglioneuromas, and 2 were NB post chemotherapy. Here, SESN2 is linked to ganglioneuroma.